SCHEMBL2841045

SCHEMBL2841045

Cc1cc2c(o1)CN(C)CCC2Oc1cccc(Cl)c1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
GPBAR1 Q8TDU6 6/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
SSTR1 P30872 2/20 0.33
SSTR4 P31391 2/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR1D P28221 2/20 0.32
HTR1B P28222 2/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2840470 0.99 GPBAR1 (0.33) ALDH1A1MAPTGAAL3MBTL1NPC1
SCHEMBL2841339 0.89 SSTR1 (0.32) SSTR1SSTR4
Hydrochloric Acid SCHEMBL2837866 0.88 SSTR1 (0.31) SSTR1SSTR4
Hydrochloric Acid SCHEMBL2835646 0.88 KDM4E (0.32) ALDH1A1MAPTGAAL3MBTL1NPC1
SCHEMBL2835759 0.82 MEN1 (0.37) L3MBTL1RAB9AKMT2A
SCHEMBL2836900 0.82 ALDH1A1 (0.34) ALDH1A1MAPTGAAL3MBTL1NPC1
Hydrochloric Acid SCHEMBL2841025 0.81 MEN1 (0.37) L3MBTL1RAB9AKMT2A
Hydrochloric Acid SCHEMBL2835500 0.81 ALDH1A1 (0.33) ALDH1A1MAPTGAAL3MBTL1NPC1
Hydrochloric Acid SCHEMBL2841936 0.81 SSTR1 (0.38) ALDH1A1LMNASSTR1SSTR4KMT2A
SCHEMBL10078928 0.79 SLC6A4 (0.40) MAPTHTTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US claimed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 ALDH1A1 66/4885MAPT 2608/4885GAA 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.